Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed with results

Key Signals

3 with results89% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (5)
Early P 1 (1)
P 1 (1)
P 2 (2)
P 3 (2)

Trial Status

Completed8
Recruiting6
Not Yet Recruiting2
Terminated1
Active Not Recruiting1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT04779320Phase 3RecruitingPrimary

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

NCT07524244Not ApplicableRecruiting

Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

NCT07528040Not Yet RecruitingPrimary

An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection

NCT04524611Phase 3Active Not RecruitingPrimary

Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

NCT07522528Not ApplicableRecruitingPrimary

Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study

NCT07337902Not ApplicableRecruitingPrimary

Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)

NCT07237516Recruiting

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

NCT07309744Early Phase 1Not Yet Recruiting

Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease

NCT07078994Phase 2RecruitingPrimary

Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease

NCT02782663Phase 2CompletedPrimary

A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease

NCT04089514Completed

A Real-world Study of Imraldi® Use

NCT04271748Not ApplicableCompletedPrimary

The Impact of Time Restricted Feeding in Crohn's Disease

NCT02775656Terminated

UCB Cimzia Pregnancy Follow-up Study

NCT03801928Completed

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

NCT02108821Phase 1Completed

Fecal Microbiota Transplantation in Pediatric Patients

NCT02778464Completed

Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease

NCT01364896Completed

Anal Human Papillomavirus in Inflammatory Bowel Disease Study

NCT01877577Not ApplicableCompletedPrimary

Supplementation of Vitamin D3 in Patients With Inflammatory Bowel Diseases and Hypovitaminosis D

Showing all 18 trials

Research Network

Activity Timeline